LRG1 as a novel therapeutic target in eye disease

Retinal and choroidal diseases are major causes of blindness and visual impairment in the developed world and on the rise due to an ageing population and diabetes epidemic. Standard of care is centred around blockade of vascular endothelial growth factor (VEGF), but despite having halved the number...

Descripción completa

Detalles Bibliográficos
Autores principales: De Rossi, Giulia, Da Vitoria Lobo, Marlene E., Greenwood, John, Moss, Stephen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807626/
https://www.ncbi.nlm.nih.gov/pubmed/34987199
http://dx.doi.org/10.1038/s41433-021-01807-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807626/
https://www.ncbi.nlm.nih.gov/pubmed/34987199
http://dx.doi.org/10.1038/s41433-021-01807-4

Ejemplares similares